Literature DB >> 17482650

Frontal cortical alpha7 and alpha4beta2 nicotinic acetylcholine receptors in working and reference memory.

Wai Kit Chan1, Peter Tsun-Hon Wong, Fwu-Shan Sheu.   

Abstract

The alpha7 and alpha4beta2 nicotinic acetylcholine receptor (nAchR) subtypes have been shown to be involved in memory. It is also known that losses of frontal cortical nAchRs are correlated to declining memory function in Alzheimer's disease, but the subtype-specific role of frontal cortical nAchRs in memory has not been well characterized. Hence, we sought to understand the role of frontal cortical alpha7 and alpha4beta2 nAchR subtypes in both working and reference memory by observing the effects of subtype specific agonists and antagonists on radial arm maze performance. It was found that alpha7 nAchRs in the frontal cortex are involved in working and reference memory, while alpha4beta2 nAchRs are only involved in working memory. Throughout the study, drug treatments did not affect motor functionality in the animals. Our data thus sheds further light on the frontal cortex as an important anatomical locus for nAchR-mediated memory function in the brain, and highlights the differing role of alpha7 and alpha4beta2 nAchRs in long and short term memory.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482650     DOI: 10.1016/j.neuropharm.2007.03.008

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  34 in total

1.  Differential expression and function of nicotinic acetylcholine receptors in the urinary bladder epithelium of the rat.

Authors:  Jonathan M Beckel; Lori A Birder
Journal:  J Physiol       Date:  2012-01-16       Impact factor: 5.182

Review 2.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 3.  Prefrontal cortical network connections: key site of vulnerability in stress and schizophrenia.

Authors:  Amy F T Arnsten
Journal:  Int J Dev Neurosci       Date:  2011-02-21       Impact factor: 2.457

4.  Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.

Authors:  Rebecca L Ashare; Sherry A McKee
Journal:  Exp Clin Psychopharmacol       Date:  2011-09-26       Impact factor: 3.157

5.  Decreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats.

Authors:  Dennis A Burke; Pooneh Heshmati; Ehsan Kholdebarin; Edward D Levin
Journal:  Eur J Pharmacol       Date:  2014-07-24       Impact factor: 4.432

Review 6.  Forgetfulness during aging: an integrated biology.

Authors:  Paul E Gold; Donna L Korol
Journal:  Neurobiol Learn Mem       Date:  2014-03-24       Impact factor: 2.877

7.  Activation of the α7 nicotinic ACh receptor induces anxiogenic effects in rats which is blocked by a 5-HT₁a receptor antagonist.

Authors:  Anshul A Pandya; Jerrel L Yakel
Journal:  Neuropharmacology       Date:  2013-01-12       Impact factor: 5.250

8.  Chronic underactivity of medial frontal cortical beta2-containing nicotinic receptors increases clozapine-induced working memory impairment in female rats.

Authors:  Edward D Levin; Abigail Perkins; Terrell Brotherton; Melissa Qazi; Chantal Berez; Janitza Montalvo-Ortiz; Kasey Davis; Paul Williams; N Channelle Christopher
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2008-12-24       Impact factor: 5.067

9.  Α4β2 and α7 nicotinic acetylcholine receptor binding predicts choice preference in two cost benefit decision-making tasks.

Authors:  I A Mendez; J C Damborsky; U H Winzer-Serhan; J L Bizon; B Setlow
Journal:  Neuroscience       Date:  2012-11-14       Impact factor: 3.590

10.  The astrocyte-derived alpha7 nicotinic receptor antagonist kynurenic acid controls extracellular glutamate levels in the prefrontal cortex.

Authors:  Hui-Qiu Wu; Edna F R Pereira; John P Bruno; Roberto Pellicciari; Edson X Albuquerque; Robert Schwarcz
Journal:  J Mol Neurosci       Date:  2009-08-19       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.